CARPENTIER-EDWARDS PERIMOUNT MAGNA PERICARDIAL BIOPROSTHESIS
Report
- Report Number
- 2015691-2019-01641
- Event Type
- Injury
- Date Received
- May 8, 2019
- Date of Event
- April 13, 2019
- Report Date
- April 13, 2019
- Manufacturer
- EDWARDS LIFESCIENCES
- Product Code
- DYE
- PMA / PMN Number
- P860057/S022
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- PHYSICIAN
Narratives
H10. ADDITIONAL MANUFACTURER NARRATIVE: EDWARDS RECEIVED ADDITIONAL INFORMATION THROUGH FOLLOW UP WITH THE HEALTHCARE PROVIDER. SUPPLEMENTAL REPORT SUBMITTED TO UPDATE B5, B7, AND F10. BASED ON THE AVAILABLE INFORMATION, THE ROOT CAUSE OF THE EVENT WAS LIKELY DUE TO PATIENT RELATED FACTORS AND THE PROGRESSION OF THE PATIENT'S UNDERLYING VALVULAR DISEASE PATHOLOGY.
EDWARDS RECEIVED ADDITIONAL INFORMATION THROUGH FOLLOW UP WITH THE HEALTHCARE PROVIDER. BASED ON THE AVAILABLE INFORMATION, THE ROOT CAUSE OF THE EVENT REMAINS INDETERMINABLE. HOWEVER, IT IS LIKELY THAT PATIENT RELATED FACTORS AND THE PROGRESSION OF THE PATIENT'S UNDERLYING VALVULAR DISEASE PATHOLOGY CONTRIBUTED TO THE EVENT.
CORRECTED DATA: F10, H6. REFERENCE CAPA-20-00141.
EDWARDS RECEIVED ADDITIONAL INFORMATION THROUGH FOLLOW UP WITH THE HEALTHCARE PROVIDER. IT WAS REPORTED A PATIENT INITIALLY IMPLANTED WITH A 23MM FOR 11 YEARS 6 MONTHS WAS EXPLANTED AND REPLACED WITH A 21MM EDWARDS VALVE DUE TO SEVERE STENOSIS WITH ELEVATED VELOCITIES ACROSS THE VALVE. THE PATIENT WAS NOTED TO BE DOING WELL WAS DISCHARGED ON POST-OPERATIVE DAY SIX.
EDWARDS RECEIVED ADDITIONAL INFORMATION THROUGH FOLLOW UP THAT THE 23MM PERICARDIAL AORTIC VALVE IMPLANTED FOR 11 YEARS 6 MONTH WAS EXPLANTED AND REPLACED WITH A 21MM EDWARDS VALVE DUE TO ELEVATED VELOCITIES ACROSS THE VALVE. THE PATIENT WAS NOTED TO BE DOING WELL.
BIOPROSTHETIC VALVES ARE KNOWN TO HAVE A LIMITED LIFE SPAN AS THE SURGICAL PROSTHESIS IS PRONE TO STRUCTURAL VALVE DEGENERATION (SVD) DUE TO A GRADUAL, MULTI-YEAR PROCESS OF CALCIFICATION OF THE LEAFLETS RESULTING FROM THE PRE-EXISTING DISEASE PROCESS. IT MAY PRESENT AS REGURGITATION AND/OR STENOSIS. THIS IS AN EXPECTED AND FORESEEABLE RESULT IN VALVES THAT HAVE BEEN IMPLANTED LONG TERM. SVD IS THE MOST COMMON REASON FOR BIOPROSTHESIS EXPLANTS/REPLACEMENTS AND ENCOMPASSES MULTIPLE FAILURE MODES, INCLUDING CALCIFICATION, NON-CALCIFIC DEGENERATION, DEHISCENCE, CUSP THICKENING OR FIBROSIS, OR A COMBINATION OF THESE. SUCH FAILURE MODES MAY OCCUR SINGULARLY OR CONCOMITANTLY. ALTERNATIVELY, NONSTRUCTURAL DYSFUNCTION (NSVD) MAY ALSO PLAY A ROLE IN THE DEVELOPMENT OF VALVULAR REGURGITATION AND/OR STENOSIS. REQUESTS FOR ADDITIONAL INFORMATION ARE CURRENTLY IN PROGRESS. THE ROOT CAUSE OF THIS EVENT CANNOT BE DETERMINED AT THIS TIME. IF ANY NEW INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED ACCORDINGLY. THE DEVICE HISTORY RECORD (DHR) REVIEW WAS COMPLETED AND THIS DEVICE PASSED ALL MANUFACTURING AND STERILIZATION INSPECTIONS PRIOR TO RELEASE FOR DISTRIBUTION. THERE WERE NO ISSUES IDENTIFIED THAT WOULD HAVE IMPACTED THIS EVENT.
IT WAS REPORTED A PATIENT IMPLANTED WITH A 23MM 3000TFX VALVE FOR 11 YEARS AND 6 MONTHS, IS PENDING A VALVE-IN-VALVE PROCEDURE. THE REASON FOR THE VALVE REPLACEMENT IS UNKNOWN. THE PROCEDURE HAS NOT BEEN SCHEDULED AT THIS TIME. NO OTHER DETAILS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 386942 | CARPENTIER-EDWARDS PERIMOUNT MAGNA PERICARDIAL BIOPROSTHESIS | REPLACEMENT HEART VALVE | DYE | EDWARDS LIFESCIENCES | 3000TFX | R-07H1654 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 83 YR | Other |